Technical Comment On: Trottmann M, Et Al. Real-World Expenditures and Survival Time After CAR-T Treatment for Large B-Cell Lymphoma in Switzerland: A Retrospective Study Using Insurance Claims Data. Swiss Med Wkly 2024, 154 (10), 3704. https://doi.org/10.57187/s.3704.